Featured Research

from universities, journals, and other organizations

Predicting effectiveness of flu vaccination campaigns

Date:
February 22, 2010
Source:
Elsevier
Summary:
A new study describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options. The model was applied to the 2009 influenza H1N1 outbreak and predicted accurately in real-time when the epidemic would peak and who should be prioritized for vaccination.

A new study published in Vaccine describes a new method that assesses the impact and cost-effectiveness of a range of vaccination options. The model was applied to the 2009 influenza H1N1 outbreak and predicted accurately in real-time when the epidemic would peak and who should be prioritized for vaccination.

Last year, an outbreak of a novel strain of influenza linked to swine influenza was detected in Mexico. The infection has shown sustained human-to-human transmission across the world, leading the World Health Organization to declare an influenza pandemic. Vaccines specific for pandemic influenza have been successfully developed and the UK Joint Committee on Vaccination and Immunization recommended that high-risk individuals be prioritized for vaccination.

Decisions about extending vaccination to low-risk individuals are heavily debated and depend partly on the epidemiological impact and cost-effectiveness of such options. Marc Baguelin, Albert Jan Van Hoek and colleagues from the Health Protection Agency and the London School of Hygiene and Tropical Medicine in the UK describe how they fit a mathematical model to the estimated number of cases in real-time to predict the effectiveness of alternative influenza vaccination strategies. Specifically, they show that, vaccination of high risk groups was probably very cost effective. However, the cost-effectiveness of vaccinating children depended on the progress of the epidemic and may be cost-effective in countries where a flu pandemic is not so far advanced.

"Given the present debates in different European countries about the legitimacy of the different choices of vaccination our paper is very topical," said Baguelin, "further it reinforces and expands a recent article in The Lancet (doi:10.1016/s0140-6736(09)62126-7) as it also suggests that many more people than first thought were infected in the summer wave of the swine flu pandemic."


Story Source:

The above story is based on materials provided by Elsevier. Note: Materials may be edited for content and length.


Journal Reference:

  1. Baguelin et al. Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine, 2010; DOI: 10.1016/j.vaccine.2010.01.002

Cite This Page:

Elsevier. "Predicting effectiveness of flu vaccination campaigns." ScienceDaily. ScienceDaily, 22 February 2010. <www.sciencedaily.com/releases/2010/02/100209182936.htm>.
Elsevier. (2010, February 22). Predicting effectiveness of flu vaccination campaigns. ScienceDaily. Retrieved August 21, 2014 from www.sciencedaily.com/releases/2010/02/100209182936.htm
Elsevier. "Predicting effectiveness of flu vaccination campaigns." ScienceDaily. www.sciencedaily.com/releases/2010/02/100209182936.htm (accessed August 21, 2014).

Share This




More Health & Medicine News

Thursday, August 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins